• 825619-29-2
    4-[[2-(4-nitro-1,2-dihydropyrazol-3-ylidene)benzimidazol-5-yl]methyl]morpholine
  • 825619-30-5
    3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-amine
  • 参考文献

    ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 228 ; WO 2007/077435 A1

  • 上一页
  • 1
  • 2
  • 3
  • ...
  • 7
  • 下一页